|
⚲
|
| Keyboard |
| Lee Phillip E
✚
|
|
|---|---|
| CIK # | 0001959565 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001959565] | |
| 4 | [0001959565] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| NABI Biopharmaceuticals | |
| Lee Phillip E |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2025-03-24 | Grant | 610,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-24 | Grant | 406,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2025-03-18 | Tax withheld | 8,050 | $0.57 | 4,588 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-12-15 | Tax withheld | 6,132 | $0.59 | 3,618 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-06-12 | Tax withheld | 2,007 | $0.76 | 1,525 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2024-03-18 | Grant | 90,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2024-03-18 | Grant | 410,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-12-15 | Tax withheld | 5,943 | $0.63 | 3,744 |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-12-08 | Tax withheld | 35,151 | $0.71 | 24,957 |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2023-06-12 | Grant | 102,500 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-06-12 | Grant | 22,500 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2023-03-17 | Grant | 205,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-17 | Grant | 90,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-17 | Grant | 56,652 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2023-03-17 | Grant | 45,000 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (Right to Buy) · derivative
|
2022-12-16 | Grant | 412,500 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Common Stock
|
2022-12-16 | Grant | 68,750 | $0.00 |